Human Papillomavirus Quadrivalent Vaccine Recombinant
About Human Papillomavirus Quadrivalent Vaccine Recombinant
Human Papillomavirus Quadrivalent Vaccine Recombinant is a preventive vaccine that protects against Human Papillomavirus (HPV) types 6, 11, 16, and 18. These HPV types are responsible for most cases of genital warts and many HPV-related cancers, including cancers of the cervix, vagina, vulva, anus, and some cancers of the throat (oropharynx). By priming your body's immune system, this vaccine helps reduce the risk of long-term health complications associated with these viral infections.
This vaccine is typically injected in a series of two or three doses over a six-month period. To achieve full, long-lasting protection, it is vital to receive all recommended doses on schedule. Because it is given as an injection, it does not matter if you have eaten recently, though having a light snack beforehand can help prevent dizziness. Supporting your immune system through a healthy diet and avoiding smoking can also help your body build a strong defense.
Most people experience only mild side effects from this injection, such as temporary soreness, redness, or swelling where the shot was given. You might also feel a mild headache or a low-grade fever shortly afterward. However, you should contact your doctor immediately if you experience signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, or severe hives.
Before receiving this vaccine, inform your healthcare provider if you have a bleeding disorder, a weakened immune system, or are currently suffering from a moderate or severe illness with a high fever. Do not receive this vaccine if you have ever had a life-threatening allergic reaction to a previous dose of this vaccine or to yeast.
This vaccine may interact with medications that suppress your immune system, such as chemotherapy or high-dose steroids, making the shot less effective. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before starting the vaccination series to ensure it is scheduled safely.
Uses of Human Papillomavirus Quadrivalent Vaccine Recombinant
• Prevention of Cervical Cancer: The main purpose of Human Papillomavirus Quadrivalent Vaccine Recombinant is to guard against cervical cancer brought on by specific human papillomavirus (HPV) strains.
• Anal Cancer Prevention: This vaccination lowers the risk of anal cancer, particularly in those who are more susceptible to anal cancers linked to HPV.
• Prevention of Genital Warts: Human Papillomavirus Quadrivalent Vaccine Recombinant works well to stop HPV strains from causing genital wart formation.
• Defense Against Additional HPV-Related Cancers: Human Papillomavirus Quadrivalent Vaccine Recombinant may help protect against vulvar and vaginal cancers, as well as cervical and anal cancers, which are all linked to HPV.
• Reducing HPV Transmission: By helping to reduce the overall rates of HPV transmission in communities, this vaccine helps to enhance public health with regard to STDs.
Medicinal Benefits
Beyond preventing HPV-related diseases, this vaccine offers several long-term health benefits, including:
- Helps protect against HPV types responsible for many cases of cervical, vaginal, vulvar, and anal cancers, as well as certain precancerous lesions.
- Reduces the risk of developing genital warts caused by specific HPV types.
- Helps prevent HPV infection before exposure, reducing the need for future diagnostic procedures and treatments related to HPV-associated disease.
- Provides long-lasting protection when the recommended vaccination schedule is completed.
- Supports community protection (herd immunity) by reducing the spread of HPV, helping lower transmission to sexual partners and protecting people who are not vaccinated or who have a weaker immune response.
Directions for Use
- It is usually given in a three-dose regimen, with the initial injection followed by subsequent doses at months 2 and 6.
- Human Papillomavirus Quadrivalent Vaccine Recombinant will be administered by a healthcare professional.
- Do not self-administer.
Storage
Side Effects of Human Papillomavirus Quadrivalent Vaccine Recombinant
Common Side Effects (Usually mild)
- Pain, redness, or swelling at the injection site
- Mild fever or chills
- Headache
- Feeling tired, dizzy, or slightly sick to your stomach
Serious Side Effects (Call a doctor right away)
- Signs of a severe allergic reaction (such as hives, swelling of the face, tongue, or throat, or trouble breathing)
- Severe dizziness, fainting, or vision changes immediately after the injection
- High fever that does not respond to fever-reducing medication
Medicines Containing this Salt
View AllDrug Warnings
- Inspect the vaccine: Ensure the healthcare professional inspects the vaccine liquid before use. It should appear as a white, cloudy suspension without any visible floating clumps or foreign particles.
- Remain under observation: Always sit or lie down during the injection and remain seated under observation for 15 minutes afterward to help prevent injury in case of fainting.
- Inform your healthcare provider about bleeding disorders: Tell your provider if you take blood thinners or have a bleeding disorder, such as hemophilia, as you may experience more bleeding or bruising at the injection site.
- Postpone vaccination if you have a high fever: Delay your scheduled injection if you are currently suffering from an acute illness accompanied by a high fever until you have fully recovered.
- Keep track of your doses: Keep a record of your vaccination dates to ensure you receive all follow-up doses on time for complete protection.
Drug Interactions
- Immunosuppressants (such as chemotherapy, high-dose steroids, or transplant medicines): May reduce the body's immune response to the vaccine, potentially making it less effective.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
cautionIt is unknown whether it is safe to consume alcohol with Human Papillomavirus Quadrivalent Vaccine Recombinant. However, it is advisable not to take or limit alcohol as a precautionary measure.
Pregnancy
cautionPlease consult the doctor. There are no adequate and well-controlled studies on pregnant women. Your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
cautionConsult your doctor as there is no substantial research yet on the use of Human Papillomavirus Quadrivalent Vaccine Recombinant in breastfeeding/nursing mothers. Your doctor will prescribe only if the benefits outweigh the risks.
Driving
safe if prescribedHuman Papillomavirus Quadrivalent Vaccine Recombinant may not affect your ability to drive.
Liver
safe if prescribedHuman Papillomavirus Quadrivalent Vaccine Recombinant is probably safe when used in patients with liver diseases. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
safe if prescribedHuman Papillomavirus Quadrivalent Vaccine Recombinant is probably safe when used in patients with kidney diseases. Your doctor will prescribe only if the benefits outweigh the risks.
Children
cautionHuman Papillomavirus Quadrivalent Vaccine Recombinant should not be used in children under nine years.
Habit Forming
Diet & Lifestyle Advise
- Eat a healthy diet: Eat a balanced, nutrient-rich diet with plenty of vitamins C, E, and folate to help support your immune system's response to the vaccine.
- Avoid smoking and tobacco: Avoid smoking and tobacco use, as smoking impairs the immune system's ability to clear viral infections and increases the risk of abnormal cervical cell changes.
- Stay hydrated: Stay well-hydrated and eat a light meal or snack shortly before your appointment to minimize the risk of feeling lightheaded or fainting during the injection.
- Continue regular screening: Continue scheduling regular cervical screenings (such as Pap smears) as advised by your doctor, as the vaccine does not protect against all less common HPV types.
Special Advise
Vaccines may develop syncope (temporary loss of consciousness), which can result in a fall with injury; therefore, observation for 15 minutes after administration is advised.
Patients Concern
Disease/Condition Glossary
Cancer: Cancer is a disease that is caused by the uncontrolled division of abnormal cells in a specific part of the body.
Genital warts: It is a common sexually transmitted infection (HPV). Symptoms include the development of small growths/bumps on the genital areas.
Cervical cancer: Cervical cancer, also known as cervix cancer, is a type of cancer that develops in the cells of the cervix. The sexually transmitted human papillomavirus is responsible for the majority of cervical cancer cases (HPV).
Anal cancer: Anal cancer is defined as abnormal cell growth in or around the anus or anal canal. The majority of anal cancers are caused by human papillomavirus (HPV) infection.
FAQs
Human Papillomavirus Quadrivalent Vaccine Recombinant is an HPV (human papillomavirus) vaccine that helps protect against infections caused by certain HPV types and prevents HPV-related diseases, including cervical cancer, genital warts, and other HPV-associated cancers. It is recommended for eligible individuals to develop immunity before exposure to the virus.
Human Papillomavirus Quadrivalent Vaccine Recombinant helps develop immunity by stimulating the immune system to produce antibodies relevant to the Human papillomavirus (HPV).
Human Papillomavirus Quadrivalent Vaccine Recombinant may result in side effects such as injection site redness, pain, swelling, fever, nausea, and headache. These side effects usually go away on their own. However, if any of these side effects persist or worsen, contact your doctor right away.
The healthcare professional administers the HPV quadrivalent vaccine in three doses. You can get your first shot at any time, as long as you are between the ages of 9 and 26. Then you will need to get a second dose two months after your first shot and a third dose six months later.
Vaccination is generally postponed during pregnancy unless your doctor determines that the benefits outweigh the risks. If pregnancy occurs after starting the vaccine series, the remaining doses are usually given after delivery. Available data suggest that the vaccine is generally considered safe during breastfeeding, but you should discuss vaccination with your healthcare provider.
Human Papillomavirus Quadrivalent Vaccine Recombinant should not be used in individuals with a weak immune system due to diseases (cancer or HIV) or medicines (immune suppressants), blood disorders, immunological diseases, and severe illness with fever.
No, Human Papillomavirus Quadrivalent Vaccine Recombinant may not be effective against all types of human papillomavirus (HPV). The quadrivalent vaccine protects against HPV types 6, 11, 16, and 18.
Human Papillomavirus Quadrivalent Vaccine Recombinant is routinely recommended for children and adolescents aged 9–14 years, when it is most effective before exposure to HPV. Older adolescents and adults up to 26 years who have not been adequately vaccinated should also receive it. Adults aged 27–45 years may still benefit in certain situations after discussion with their healthcare provider.
Yes, you can have Human Papillomavirus Quadrivalent Vaccine Recombinant even though you are not a virgin anymore. Human Papillomavirus Quadrivalent Vaccine Recombinant will be effective even though you are sexually active and protect against HPV you haven’t been exposed to. However, it does not protect against HPV infections you already have.
You may not need to start over again. However, please consult the doctor if you didn't get the last dose of Human Papillomavirus Quadrivalent Vaccine Recombinant.
Yes. Regular cervical screening (Pap smear or other recommended screening tests) is still necessary because Human Papillomavirus Quadrivalent Vaccine Recombinant does not protect against all HPV types that can cause cervical cancer. Continue screening according to your doctor's recommendations.
Human Papillomavirus Quadrivalent Vaccine Recombinant is highly effective in preventing diseases caused by the HPV types included in the vaccine when the recommended doses are completed, especially if vaccination occurs before exposure to HPV.
Human Papillomavirus Quadrivalent Vaccine Recombinant has a favourable safety profile and is generally safe and well tolerated. The most common side effects are mild and include pain, redness, swelling, itching, or bruising at the injection site, fever, nausea, headache, and dizziness. These usually resolve without treatment. Consult your doctor if side effects are severe or persistent.
Human Papillomavirus Quadrivalent Vaccine Recombinant is a quadrivalent vaccine or immunising agent which is made from a live and weakened or attenuated virus.
Yes. Human Papillomavirus Quadrivalent Vaccine Recombinant can generally be administered at the same time as other vaccines, provided they are given using separate syringes and at different injection sites. Inform your doctor about all vaccines you are receiving.
Though using a condom in the right way will lower the risk of HPV, it may not provide full protection as HPV can affect the areas the condom does not cover. HPV can be transmitted not only through penetrative sex but also through oral sex or genital-to-genital contact. Engage in mutual monogamy or limit your sexual activity to someone who exclusively engages in sexual activity with you.
No, girls and women may not need to be screened for cervical cancer before getting vaccinated.
Human Papillomavirus Quadrivalent Vaccine Recombinant is recommended for routine vaccine in 9-12 years. The maximum age is 26 years if not adequately vaccinated when younger.
A quadrivalent vaccine protects against 4 types of HPV (human papillomavirus). It is effective against diseases caused by HPV types 6, 11, 16 and 18.
No, this vaccine is strictly preventive and cannot treat an existing infection, active genital warts, or cancer. Talk to your doctor if you currently have symptoms of an infection.
The number of doses depends on your age when you receive the first shot, usually requiring either two or three injections spread over several months. Talk to your doctor to confirm your specific schedule.
Yes. The vaccine is recommended for males to help prevent genital warts, anal cancer, and certain other HPV-related diseases. Vaccinating boys and men also helps reduce the spread of HPV to their partners and contributes to community protection (herd immunity), benefiting the wider population. Talk to your doctor to find out if it is appropriate for you.
Author Details
